ALB vs LYRA · rev $1.74B vs rev $1.5M
Albemarle Corp (ALB) versus Lyra Therapeutics Inc (LYRA) — a side-by-side from cached financials, not a winner call.
Albemarle Corp (ALB) is a specialty chemicals company listed on US.
Lyra Therapeutics Inc (LYRA) is a biotechnology company listed on US.
Latest reported ALB revenue for 2026-06-30 was $1.74B. Net income was $480.0M. Revenue was up 22.0% from 2026-03-31 to 2026-06-30. ALB currently screens at market cap $8.00B.
Latest reported LYRA revenue for 2024-12-31 was $1.5M. Net income was -$93.4M. Revenue was down 1.5% from 2023-12-31 to 2024-12-31. LYRA currently screens at market cap $14.4M.
ALB currently screens at market cap $8.00B. LYRA currently screens at market cap $14.4M.
Not investment advice. Open the ALB and LYRA stock pages for the full models.
Not investment advice.